Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Pro-apoptotic effect of ZT-12-037-01 is dramatically enhanced in cells expressing oncogenic NRAS
MM-102 (HMTase Inhibitor IX) dose-dependently inhibits cell growth in the MV4
Chemical Name: 7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3R)-piperidin-3-yl]-1H
thereby interrupting DNA synthesis and inhibiting tumor cell growth
Canagliflozin - CAS# 842133-18-0 Catalog No.:M10730-10 Pro-apoptotic effect of ZT-12-037-01 isCanagliflozin (INN, trade name Invokana) is a drug for the treatment of type 2 diabetes. It was developed by Mitsubishi Tanabe Pharma and is marketed under license by Janssen, a division of Johnson & Johnson. Canagliflozin is an inhibitor of subtype 2 sodium glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the
US$ 17.95
US$ 205.62
US$ 97.32
US$ 34.95
US$ 23.95
US$ 27.00
US$ 119.38
US$ 21.95
US$ 114.82
US$ 107.94
US$ 41.06
US$ 113.64
US$ 100.28